Karyn Yonekawa

A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children

Stuart L. Goldstein, Devesh Dahale, Eric S. Kirkendall et al. · Kidney International · 2019 · 158 citations

Renal Function, Renal Disease, Patient Safety +7

Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography

Guy Young, Karyn Yonekawa, Peggy Nakagawa et al. · Blood Coagulation & Fibrinolysis · 2007 · 105 citations

Anticoagulant Effects, Factor Vii, Reversal Ability +18

Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits

Guy Young, Karyn Yonekawa, Peggy Nakagawa et al. · Perfusion · 2004 · 58 citations

Prevention of Urinary Stones With Hydration (PUSH): Design and Rationale of a Clinical Trial

Charles D. Scales, Alana Desai, Jonathan D. Harper et al. · American Journal of Kidney Diseases · 2020 · 40 citations · Full text

Urological Research, Urology, Voiding Dysfunction +4

Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children

Elizabeth Goswami, Richard Ogden, William E. Bennett et al. · American Journal of Health-System Pharmacy · 2019 · 37 citations · Full text